Liminatus Pharma (LIMN) Total Liabilities (2024 - 2026)
Liminatus Pharma (LIMN) posted Total Liabilities of $2.9 million for Q1 2026, down 71.7% sequentially from $10.3 million in Q4 2025, and up 275640.09% YoY from N/an in Q1 2025.
Liminatus Pharma (LIMN) Total Liabilities (2024 - 2026) Analysis & Trends
Liminatus Pharma has reported Total Liabilities for 3 years, with the latest figure at $2.9 million in Q1 2026.
- Quarterly Total Liabilities rose 275640.09% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (up 275640.09% YoY) and the FY2025 annual result came in at $10.3 million, down 58.27% from the prior year.
- Total Liabilities retreated to $2.9 million in Q1 2026 per LIMN's latest filing, from $10.3 million in the prior quarter.
- Over five years, Total Liabilities peaked at $24.7 million in Q4 2024 and troughed at $1060.0 in Q1 2025.
- A 3-year average of $8.6 million and a median of $6.7 million in 2025 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2025 and 2026: Total Liabilities slumped 58.27% in 2025, then surged 275640.09% in 2026.
- Over 3 years, Total Liabilities stood at $24.7 million in 2024, then plunged by 58.27% to $10.3 million in 2025, then tumbled by 71.7% to $2.9 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $2.9 million, $10.3 million, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.20 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.35 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 10.03 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 3.22 Bn |
| 10 | Liminatus Pharma | 5.46 Mn | 5.46 Mn | - | 3.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.92 Mn |
| Dec 31, 2025 | 10.33 Mn |
| Sep 30, 2025 | 2.99 Mn |
| Jun 30, 2025 | 10.72 Mn |
| Mar 31, 2025 | 1,060.00 |
| Dec 31, 2024 | 24.75 Mn |